London, United Kingdom-based provider of a digital musculoskeletal (MSK) health platform for workplaces, Vitrue Health, raised USD 4 million (EUR 3.7 million) in funding. The round took place on February 29, 2024.
The round brought the total financing to EUR 6.5 million. MMC Ventures and Hambro Perks led the financing for the company. Meanwhile, Simplyhealth Ventures, Crista Galli Ventures, and Chris Bruce joined in the funding.
Purpose of financing for Vitrue Health
With the latest investment, Vitrue Health seeks to grow the team further. It also has plans to advance its expansion across the USA and new markets in Europe. In addition, the new proceeds funds research into other forms of assessment and clinical use cases.
What the company’s official has to add
Shane Lowe, Co-Founder and CEO at Vitrue Health, said, “Musculoskeletal health conditions have been a societal problem across the world for decades, and our data shows that rates of pain have massively increased since the rise of hybrid working. With this new funding, we’ll be able to continue our growth to reduce the financial and health costs for employers and their teams.”
What the investors have to comment
Simon Menashy, Partner at MMC Ventures, further added, “We’ve been tracking Vitrue Health and the evolution of its computer vision technology for several years. The team is highly technical with a strong clinical skill set, and we believe they’ve found a strong use case with evidenced product-market fit that can eliminate musculoskeletal pain for millions of people.”
Besides, Nick Sharp, Partner at Hambro Perks, commented, “Vitrue has made great progress in its vision to fix a global pain point with their unique tech solution. We’ve been very impressed with the product and commercial development, and the evidence showing prevention in MSK issues and a reduction in pain for those living with conditions.”
About the company
Shane Lowe & Alexandra Haslehurst are the co-founders of the company. Vitrue Health leverages computer vision and AI to analyse the posture and ergonomics of home, site and office-based workers. It further provides a personalised program to improve their equipment use, behaviour, risk prevention, injury management, as well as even psychology. Originally inspired by injury prevention tactics in elite athletes, 92% of users reported reduced pain after utilizing the platform.
Since its inception in 2018, Vitrue has collaborated with firms such as Bupa, the NHS, Hastings Direct, and Campari in 30 countries to prevent and intervene before MSK concerns become significant.
To explore more such startups, visit Zefyron Startup Database
For more extensive analysis and Market Intelligence reports, feel free to approach us.
We try our best to fact-check and bring well-researched as well as non-plagiarized content to you. Please let us know
if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover
–what information you are looking for in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!
Next Article
 health platform for workplaces, Vitrue Health, raised USD 4 million (EUR 3.7 million) in funding.){kind=link}